- Report
- March 2024
- 192 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- March 2024
- 189 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- November 2023
- 650 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Clinical Trials
- April 2024
- 220 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Clinical Trials
- April 2024
- 85 Pages
Global
From €1923EUR$2,000USD£1,650GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,237GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1202EUR$1,250USD£1,031GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1202EUR$1,250USD£1,031GBP
- Report
- April 2023
- 501 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- September 2020
- 82 Pages
Global
From €3606EUR$3,750USD£3,093GBP
- Report
- May 2023
- 220 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Drug Pipelines
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
The Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. These drugs are used to target and destroy cancer cells, reduce the size of tumors, and reduce the spread of cancer. Tumor drugs are typically divided into two categories: cytotoxic drugs, which kill cancer cells, and targeted therapies, which target specific molecules involved in cancer growth. These drugs are often used in combination with other treatments, such as radiation and surgery, to maximize the effectiveness of treatment.
The Tumor Drug market is highly competitive, with many companies developing and selling drugs to treat cancer. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as AstraZeneca, Eli Lilly, and Amgen, are also active in the market. Show Less Read more